INS and type 1 diabetes mellitus: A long clinical history of symptomatic type 1 diabetes prior to exogenous insulin supplementation (i.e., initiation of therapy) and the concomitant ketoacidosis significantly reduce the likelihood of surviving residual insulin function and, thus, the consistency of remission.